69 related articles for article (PubMed ID: 8327567)
1. [The pharmacokinetics of a new anti-arrhythmic substance, Z-2-amino-5-chlorobenzophenoneamidinohydrazone (AWD-G256)].
Farker K; Henschel L; Marschner JP; Reimann I; Volkmann H; Hoffmann A
Pharmazie; 1993 May; 48(5):373-80. PubMed ID: 8327567
[TBL] [Abstract][Full Text] [Related]
2. [The pharmacokinetics of Z-2-amino-5-chlorobenzophenoneamidinohydrazone in the rat].
Schieweck A; offchert HH; Morgenroth U; Joram U
Pharmazie; 1993 May; 48(5):370-3. PubMed ID: 8327566
[TBL] [Abstract][Full Text] [Related]
3. [Biotransformation and excretion of Z-2-amino-5-chlorobenzophenoneamidinohydrazone].
Borchert HH; Schieweck A; Franke P; Morgenroth U; Joram U
Pharmazie; 1993 May; 48(5):365-70. PubMed ID: 8327565
[TBL] [Abstract][Full Text] [Related]
4. Investigations into a new antiarrhythmic substance Z-2-amino-5-chlor-benzophenon-amidin-hydralazin in humans.
Farker K; Henschel L; Marschner JP; Reimann I; Volkmann H; Hoffmann A
Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):513-4. PubMed ID: 1490815
[TBL] [Abstract][Full Text] [Related]
5. [Clinical-electrophysiologic studies on the actions of the anti-arrhythmic substance AWD-G256 in man].
Volkmann H; Hoffmann A; Kühnert H; Dannberg G; Heinke M; Reimann I; Marschner JP; Farker K
Pharmazie; 1993 May; 48(5):380-5. PubMed ID: 8327568
[TBL] [Abstract][Full Text] [Related]
6. [Hemodynamic effects and adverse effects of the anti-arrhythmic substance AWD-G256 in man].
Volkmann H; Dannberg G; Kühnert H; Hoffmann A; Marschner JP; Reimann I; Farker K
Pharmazie; 1993 May; 48(5):385-7. PubMed ID: 8327569
[TBL] [Abstract][Full Text] [Related]
7. [Anti-arrhythmia action of amidinohydrazone substituted benzophenones. 6. Parenteral drug forms of (Z)-2-amino-5-chlorobenzophenone amidinohydrazone acetate (G 256)].
Schleuder M; Keckeis A; Richter PH; Jira T
Pharmazie; 1994 Sep; 49(9):653-6. PubMed ID: 7972310
[TBL] [Abstract][Full Text] [Related]
8. [The pharmacokinetics and metabolism of bonnecor in rats].
Klemm V; Morgenroth U; Starke F; Zeriatke W; Ioram U
Farmakol Toksikol; 1990; 53(3):43-4. PubMed ID: 2387379
[TBL] [Abstract][Full Text] [Related]
9. Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervals.
Sundberg S; Antila S; Scheinin H; Häyhä M; Virtanen M; Lehtonen L
Int J Clin Pharmacol Ther; 1998 Dec; 36(12):629-35. PubMed ID: 9876999
[TBL] [Abstract][Full Text] [Related]
10. [Amiodarone absorption and elimination after oral and intravenous administration in healthy individuals].
Gaete LE; Ortiz M; Soto J; Saavedra I
Rev Med Chil; 1995 Jun; 123(6):713-9. PubMed ID: 8525224
[TBL] [Abstract][Full Text] [Related]
11. Population modelling to describe pharmacokinetics of amiodarone in rats: relevance of plasma protein and tissue depot binding.
Campos Moreno E; Merino Sanjuán M; Merino V; Nácher A; Martín Algarra RV; Casabó VG
Eur J Pharm Sci; 2007 Feb; 30(2):190-7. PubMed ID: 17218087
[TBL] [Abstract][Full Text] [Related]
12. Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil.
Krecic-Shepard ME; Barnas CR; Slimko J; Schwartz JB
Clin Pharmacol Ther; 2000 Sep; 68(3):286-92. PubMed ID: 11014410
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of desethylamiodarone in the rat after its administration as the preformed metabolite, and after administration of amiodarone.
Shayeganpour A; Hamdy DA; Brocks DR
Biopharm Drug Dispos; 2008 Apr; 29(3):159-66. PubMed ID: 18161885
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of long-term oral amiodarone therapy.
Pollak PT; Bouillon T; Shafer SL
Clin Pharmacol Ther; 2000 Jun; 67(6):642-52. PubMed ID: 10872646
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of an extemporaneous suspension of propafenone made from tablets.
Olguín HJ; Pérez CF; Pérez JF; Mendiola BR; Portugal MC; Chávez JB
Biopharm Drug Dispos; 2006 Jul; 27(5):241-5. PubMed ID: 16586461
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of fomepizole produces similar blood levels as identical intravenous dose.
Marraffa J; Forrest A; Grant W; Stork C; McMartin K; Howland MA
Clin Toxicol (Phila); 2008 Mar; 46(3):181-6. PubMed ID: 18344099
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect of mizolastine on the safety and pharmacokinetics of digoxin administered orally in repeated doses to healthy volunteers.
Chaufour S; Le Coz F; Denolle T; Dubruc C; Cimarosti I; Deschamps C; Ulliac N; Delhotal-Landes B; Rosenzweig P
Int J Clin Pharmacol Ther; 1998 May; 36(5):286-91. PubMed ID: 9629994
[TBL] [Abstract][Full Text] [Related]
18. [Anti-arrhythmic actions of amidinohydrazone substituted benzophenones. 7. Synthesis of C14 labeled (Z)- and (E)-2-amino-5-chlorbenzophenonamidinohydrazone].
Bubner M; Kasbohm K; Heise KH; Richter PH
Pharmazie; 1995 Jan; 50(1):71-2. PubMed ID: 7886129
[No Abstract] [Full Text] [Related]
19. Pharmacokinetics and oral bioavailability of pentoxyfylline in broiler chickens.
De Boever S; Baert K; De Backer P; Croubels S
J Vet Pharmacol Ther; 2005 Dec; 28(6):575-80. PubMed ID: 16343291
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetic and electocardiographic study of oral verapamil sustained-release tablet in 10 Chinese volunteers].
Liu XD; Xie L; Wang J; Zhou YS; Wang Z; Liu GQ
Yao Xue Xue Bao; 1996; 31(7):487-91. PubMed ID: 9772689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
